▶ 이 책은 한국농촌경제연구원의 농업부문 바이오소재 산업의 현황과 과제를 다룬 정부간행물입니다.

제1장 서론
1. 연구의 배경과 목적 ··············································································1
2. 연구범위 ·································································································4
3. 선행연구 검토 ························································································7
4. 연구방법 ·······························································································15
5. 보고서의 구성 ······················································································16

제2장 바이오소재 산업 현황
1. 바이오산업 현황 ··················································································19
2. 바이오소재 산업 현황 ········································································25
3. 시사점 ···································································································38

제3장 바이오 및 바이오소재 R&D 실태
1. 바이오 및 바이오소재 R&D 투자 ····················································41
2. 바이오 및 바이오소재 R&D 성과 ····················································50
3. 시사점 ···································································································59

제4장 바이오소재 산업화 현황 분석
1. 단계별 바이오소재 산업화 실태 ·······················································61
2. 농생명자원의 바이오소재화 사례 ······················································71
3. 시사점 ···································································································82

제5장 국내 바이오 및 바이오소재 관련 정책 동향
1. 생명공학 육성 및 연구개발 지원 정책 ············································85
2. 농식품 분야 바이오산업 육성 정책 ··················································94

제6장 해외 바이오소재화 사례와 시사점
1. 브리지스톤 社의 바이오소재 타이어 ················································99
2. 니코케미컬 社의 슈가 스쿠알렌 ······················································107
3. Metabolix 社의 바이오플라스틱 ······················································113
4. 시사점 ·································································································119

제7장 결론 및 시사점
1. 연구결과의 요약 ················································································121
2. 시사점 및 정책과제 ··········································································125

부록
1. 바이오산업 분류체계 ········································································135
2. 바이오소재 수급 실태 조사 ·····························································137
3. 바이오소재 수급 실태 조사표 ·························································139
4. 바이오기업의 바이오소재 수급 및 활용 관련 의견 ····················· 147
5. 아모레퍼시픽의 공공 R&D 참여 현황 ···········································150

참고문헌 ·····································································································153